Taiwan consensus of pharmacological treatment for bipolar disorder.
Bipolar disorder is an important psychiatric disorder with different disease phases. The pharmacological treatment is complicated, and is updated frequently as new research evidence emerges. For the purpose of international collaboration, research, and education, the Taiwan consensus of pharmacological treatment for bipolar disorders was initiated by the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN) - the Bipolar Chapter, which was established in August 2010 and approved as a member of International Society of Bipolar Disorder. TSBPN is the country member of the World Federation of Societies of Biological Psychiatry (WFSBP). The development of the Taiwan consensus for bipolar disorder was mainly based on the template of WFSBP Guidelines, with references to other international guidelines including the Canadian Network for Mood and Anxiety Treatments, and British Association for Psychopharmacology. We have also added Taiwanese experts' experience, Taiwan national health insurance data, and the indications for the pharmacological treatment of bipolar disorder given by the Taiwan Department of Health, to emphasize the balance between efficacy and safety, and to make this consensus a concise, empirical, and important reference for clinical psychiatric practice.
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Ya-Mei
YM
Bai
Ching-Jui
CJ
Chang
Shang-Ying
SY
Tsai
Yi-Chyan
YC
Chen
Mei-Chun
MC
Hsiao
Cheng-Ta
CT
Li
Peichi
P
Tu
Shang-Wen
SW
Chang
Winston W
WW
Shen
Tung-Ping
TP
Su
D001714:Bipolar Disorder / Q000188:drug therapy*; D032921:Consensus; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013624:Taiwan
Taiwan; bipolar disorder; consensus; pharmacotherapy